Thermal remodelling of Alternanthera mosaic virus virions and virus-like particles into protein spherical particles

Abstract

The present work addresses the thermal remodelling of flexible plant viruses with a helical structure and virus-like particles (VLPs). Here, for the first time, the possibility of filamentous Alternanthera mosaic virus (AltMV) virions’ thermal transition into structurally modified spherical particles (SP) has been demonstrated. The work has established differences in formation conditions of SP from virions (SPV) and VLPs (SPVLP) that are in accordance with structural data (on AltMV virions and VLPs). SP originate from AltMV virions through an intermediate stage. However, the same intermediate stage was not detected during AltMV VLPs’ structural remodelling. According to the biochemical analysis, AltMV SPV consist of protein and do not include RNA. The structural characterisation of AltMV SPV/VLP by circular dichroism, intrinsic fluorescence spectroscopy and thioflavin T fluorescence assay has been performed. AltMV SPV/VLP adsorption properties and the availability of chemically reactive surface amino acids have been analysed. The revealed characteristics of AltMV SPV/VLP indicate that they could be applied as protein platforms for target molecules presentation and for the design of functionally active complexes.

About the Authors:

Tatiana I. Manukhova

Roles Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Faculty of Biology, Department of Virology, Lomonosov Moscow State University, Moscow, Russia

ORCID logo https://orcid.org/0000-0001-9498-1257

Ekaterina A. Evtushenko

Roles Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing

* E-mail: [email protected]

Affiliation: Faculty of Biology, Department of Virology, Lomonosov Moscow State University, Moscow, Russia

Alexander L. Ksenofontov

Roles Investigation, Methodology, Resources, Writing – review & editing

Affiliation: Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia

Alexander M. Arutyunyan

Roles Investigation, Methodology, Resources, Writing – review & editing

Affiliation: Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia

Angelina O. Kovalenko

Roles Investigation, Writing – review & editing

Affiliation: Faculty of Biology, Department of Virology, Lomonosov Moscow State University, Moscow, Russia

ORCID logo https://orcid.org/0000-0001-9786-7652

Nikolai A. Nikitin

Roles Investigation, Methodology, Project administration, Resources, Visualization, Writing – review & editing

Affiliation: Faculty of Biology, Department of Virology, Lomonosov Moscow State University, Moscow, Russia

ORCID logo https://orcid.org/0000-0001-9626-2336

Olga V. Karpova

Roles Conceptualization, Resources, Supervision, Writing – review & editing

Affiliation: Faculty of Biology, Department of Virology, Lomonosov Moscow State University, Moscow, Russia

Introduction

Alternanthera mosaic virus (AltMV) is a member of the genus Potexvirus, family Alphaflexiviridae [1]. A previously characterised strain, AltMV-MU (Moscow University) (accession number FJ822136 in the GenBank), was used [2]. AltMV-MU (further AltMV) virions are helical filamentous particles 570 nm in length and 13 nm in diameter, consisting of RNA and coat protein (CP). AltMV CP self assembles in vitro in the absence of viral RNA into extended polymers (virus-like particles, VLPs) whose length varies within the range 60–2000 nm [3]. According to our earlier results [4], despite AltMV VLPs and virions having a morphological similarity, they differ in structure, as revealed indirectly by trypsin hydrolysis and then confirmed by cryoelectron microscopy. Firstly, the diameter of AltMV VLPs (152 Å) is larger than AltMV virions (135 Å). Also, the number of CP subunits per turn is greater for VLPs (~9.55 compared to 8.75 in virions), while the pitch of the helix is the same for both types of particle (~35.7 Å). The inner channel of VLPs is wider (~30 Å for VLPs and 20 Å for virions) due to the absence of viral RNA [4]. Previously, we reported that some helical plant viruses (tobacco mosaic virus (TMV), potato virus X (PVX)) can generate structurally modified spherical particles (SP) after heating at 94°C or 90°C, respectively. TMV and PVX SP contain only thermally denatured CP molecules and lack viral RNA [5,6]. It has been established that TMV SP diameter depends on initial virus concentration and varies from 50 nm upwards [5]. At the same time, such a clear dependence was not detected between initial virus concentration and the size of SP formed from PVX [6]. We found that the structure of the protein in TMV SP and PVX SP differs markedly from that in native virions. One of the most distinctive features of SP protein is the low proportion of α-helix structures and the considerable percentage of β- and disordered structures, in contrast to the protein within intact virions [6,7]. We also demonstrated that TMV SP are highly stable in the context of various factors (temperature, storage, centrifugation) and possess unique adsorption properties [5,8–11]. Additionally, it has been revealed that the virions to SP transition is accompanied by changes in the composition of surface amino acids which apparently affect adsorption capacity [12]. TMV SP demonstrate great potential for various biotechnology applications. We revealed the effective adjuvant properties of TMV SP, which have enabled their implementation in the development of a candidate vaccine against rubella [11]. Furthermore, it has been shown that TMV SP elicits a potent antitumour immunity, slows tumour growth and increases survival time [13]. TMV SP are able to form complexes with chelated paramagnetic gadolinium that provide a perspective contrast agent for magnetic resonance imaging [14]. Additionally, it has been established that TMV SP can bind gold nanoparticles [15] and could be applied as a biotemplate for the linking of silver nanoparticles [16] that can serve as a basis for developing new approaches to antiviral [17] and antibacterial treatment [18]. AltMV was chosen to continue the study of helical plant viruses’ thermal remodelling and the properties of formed SP. As we reported earlier [19], it is possible to obtain SP from AltMV VLPs (SPVLP) under conditions suitable for PVX and TMV SP formation. However, SP were not obtained from AltMV virions (SPV) under such experimental conditions. Therefore, it was intriguing to find conditions appropriate for deriving SPV and to compare the properties of SPV and SPVLP.

Materials and methods

Virus purification and coat protein isolation

AltMV-MU viral strain was accumulated in Nicotiana benthamiana and isolated according to an existing protocol for AltMV purification using a Himac CP100WX ultracentrifuge (Hitachi, Hitachinaka City, Japan) [4]. AltMV CP was isolated using the method of salt deproteinisation with 2M LiCl, as described previously [2,20].

RNA extraction

To assess whether RNA was present in SPV, samples obtained by a protocol described below were precipitated. Precipitation was carried out by low-speed (700 g) centrifugation, using a Microspin FV-2400 (BioSan, Riga, Latvia) for 5 min. The resulting pellet of SPV was resuspended in Milli-Q water (Simplicity UV; Millipore, Billerica, USA) and was used for RNA isolation according to [21].

AltMV SP generation

SPV and SPVLP were generated by virions/VLPs being heated to 98°C for 10 sec (experiments characterising stages of thermal transition into SPV and SPVLP) or 30 sec (in other cases) in the Tercyc thermocycler (DNA Technology, Moscow, Russia). SPV were obtained in 0.15 M NaCl solution, while SPVLP were generated in Milli-Q water.

Transmission electron microscopy

Samples were prepared using standard procedures [4] and observed using a transmission electron microscope, JEOL JEM-1400 TEM (JEOL, Tokyo, Japan). Images were recorded on an Olympus Quemesa digital camera, using iTEM software (Olympus Soft Imaging Solutions GmbH, Munster, Germany). SP diameter was measured using an image processing program designed for scientific multidimensional images, ImageJ (National Institutes of Health, Bethesda, Maryland, USA). SP sizes are presented as the mean ± SD.

Electrophoresis analysis

RNA analysis was performed in 1% agarose gel, according to [22]. Proteins were studied by electrophoresis in SDS-PAGE (8–20%), as described in [5]. Gels were imaged and analysed using the ChemiDoc™ XRS+ System, with Image Lab™ Software (Bio-Rad Laboratories, Hercules, California, USA).

Spectra measurements

Milli-Q water was used in the case of AltMV VLPs and SPVLP, 15 mM NaCl solution was used for SPV and 12.5 mM Tris-HCl pH 8.0 was used in the case of AltMV virions for far-UV CD and intrinsic fluorescence measurements. CD spectra in the 200–260 nm region were recorded in 1–2 mm cells at 25°C, using a Chiroscan CD spectrometer (Applied Photophysics, Surrey, UK). Sample concentrations were in the range of 0.1–0.3 mg/ml. The spectra were recorded at a speed of 0.5–1.0 nm/s with baseline subtraction. The spectra measured were smoothed using the instrument software Pro Data. The [ϴ] values were calculated taking the mean molecular weight of amino acid residues to be 110. The intrinsic fluorescence spectra were recorded in 1 cm cells, using a FluoroMax spectrofluorometer (HORIBA Jobin Yvon, Edison, NJ, USA), at 25°C. Fluorescence was excited at 280 nm and the emission spectra were recorded in the 300–400 nm range.

Thioflavin T (ThT) fluorescence assay

AltMV virions, VLPs and SPV/VLP were mixed with freshly prepared ThT (Sigma-Aldrich, St. Louis, MO, USA) according to [23]. The fluorescence emission spectra were measured between 450 and 620 nm, with excitation at 445 nm, using a FluoroMax spectrofluorometer. The background ThT fluorescence was measured using ThT buffer only.

Fluorescence labelling

The procedure of fluorescein isothiocyanate (FITC) (Sigma-Aldrich, St. Louis, MO, USA, 3326-32-7) labelling of AltMV virions, VLPs and SPV/VLP was carried out in accordance with the manufacturer’s protocol, with some modifications. The initial concentration of the samples before labelling was at least 1 mg/ml. Labelling was performed in 0.1 M sodium carbonate buffer, pH 9. To 1 ml of samples, 50 μl of FITC solution (1 mg/ml) was added and then samples were incubated in the dark, overnight, at 4°C. To remove unbound FITC, the labelled samples were dialysed for 4 h against phosphate-buffered saline (PBS) and for 1 h against Milli-Q water. The 5-(N-Maleimido)-fluorescein diacetate (Chem-impex, Wood Dale, USA, 22988) labelling procedure was carried out in accordance with [24]. The results of labelling were detected by fluorescence microscopy, using an Axiovert 200M fluorescence microscope (Carl Zeiss, Gottingen, Germany) equipped with a digital cooled camera ORCAII-ERG2 (Hamamatsu Photonics K.K, Hamamatsu City, Japan), and by SDS-PAGE electrophoresis with subsequent analysis in UV light using the ChemiDoc™ XRS+ System.

Adsorption properties study

100 μg of SPV/VLP were incubated with 10 μg of model antigen, (recombinant protein containing repeated sequences of influenza virus A M2e epitope, MW 24 kDa), in water and at room temperature, overnight. Then, the complexes were centrifuged at Microspin FV-2400 for 5 min to remove unbound proteins. The sedimented complexes were resuspended in Milli-Q water and prepared for immunofluorescence microscopy according to a protocol described previously [9]. For complexes detection, an Axiovert 200M fluorescence microscope equipped with a digital cooled camera, ORCAII-ERG2, was used.

Data analysis

SP size statistical differences were analysed using one-way ANOVA with a post hoc Tukey HSD test. Probability values (p values) of less than 0.05 were considered to be significant. The data are presented as mean ± SD.

CD spectra were recorded three to five times, averaged and smoothed using the instrument software Pro Data. Two independent experiments were carried out. The data of the secondary structure content are calculated as the mean ± SEM of two experiments.

In the case of intrinsic fluorescence and ThT assay, three independent experiments were conducted. Fluorescence maxima are calculated as the mean ± SEM.

Results and discussion

Previously, it was demonstrated that the heating of AltMV virions under conditions suitable for PVX and TMV virions did not result in the generation of AltMV SPv [19]. To identify specific conditions that are suitable for AltMV virions’ transformation to SPv, an attempt was made to heat virions to 98°С, in various buffers (S1 Fig). Particles similar to SP from PVX were generated after treatment in PBS pH 7.4 (S1A Fig). In other conditions, only irregular structures that had a tendency to aggregate were detected (S1B–S1D Fig). It became apparent that the key component of PBS determining AltMV SPV formation is 0.15 M NaCl (S1F Fig). After the same treatment in 0.01 М phosphate buffer, рН 7.4, no SPV were detected (S1E Fig). However, according to our earlier results [19], AltMV VLPs successfully transform into SPVLP after heating in Milli-Q water. Apparently, SPV and SPVLP form in different conditions, because of the differences in virions’ and VLPs’ structural characteristics, including RNA-protein interactions in virions and the absence of RNA in VLPs [4].

Here, several temperature points of the structural transition of AltMV virions and VLPs into SP were analyzed. AltMV virions were incubated at different temperatures (50°C, 55°C, 60°C, 94°C) for 10 sec. At 50°C, only unmodified AltMV virions were detected (Fig 1A). However, heating to 55°C led to swelling at one end of the virion (Fig 1B). This modified state of virions represents the intermediate form (IF). Upon further heating to 60°C, in addition to the IF referred to in Fig 1B, there was the appearance of IF with greater thickening at the end of the virion (Fig 1C). Subsequent heating to 94°C resulted in mature SPV formation (Fig 1D). There were no visible differences in SPV morphology at either 94°C or 98°C (S1F Fig).

[Figure omitted. See PDF.]

Fig 1. The stages of thermal transition during the formation of SP from AltMV virions.

A) AltMV virions after thermal treatment at 50°C; B) intermediate form, thermal treatment at 55°C; C) intermediate form, thermal treatment at 60°C; D) SPV formed after thermal treatment at 94°C. Transmission electron microscopy, staining with 2% uranyl acetate. Arrows indicate the swelling at the end of the virion (intermediate form). Thermal treatment was carried out for 10 sec. Bars are 200 nm in A, B, C; bar is 400 nm in D.

https://doi.org/10.1371/journal.pone.0255378.g001

Therefore, the temperatures required for structural transformation are not similar for two flexible filamentous potexviruses (AltMV and PVX). The AltMV IF was observed at a lower temperature (55°C for AltMV) than the PVX (70°C); while mature AltMV SPV were produced after heating at 94°C, mature PVX SP were detected at 90°C [6]. It is assumed that structural transition temperature may depend on buffer composition. AltMV SPV need 0.15 М NaCl, while PVX SP form in Milli-Q water or in 0.01 M Tris-HCl, pH 7.8. This hypothesis is consistent with data that suggest that NaCl may increase proteins’ thermal stability [25]. Differences in the SP formation conditions of two morphologically similar helical viruses (AltMV and PVX) belonging to the same genus will demonstrate the impact of structural viruses’ features on the thermal remodelling.

The process of structural remodelling for SPVLP was also studied. No IF was detected similar to virions with a swollen end. At 40°C, morphologically stable VLPs were observed (Fig 2A). VLPs heated to 45°C resulted in partial SPVLP formation, but some VLPs stayed in unmodified filamentous form (Fig 2B). Upon a further increase in the temperature to 60°C, both SPVLP and VLPs were detected (Fig 2C–2E). Heating to just 65°C resulted in all VLPs transforming into SPVLP (Fig 2F).

[Figure omitted. See PDF.]

Fig 2. The stages of thermal transition during the formation of SPVLP.

A) Thermal treatment of AltMV VLPs at 40°C; B), C), D), E) thermal treatment of AltMV VLPs at 45°C, 50°C, 55°C and 60°C, respectively; F) SPVLP formed after thermal treatment of AltMV VLPs at 65°C. Transmission electron microscopy, staining with 2% uranyl acetate. Thermal treatment was carried out for 10 sec. Bars, 500 nm.

https://doi.org/10.1371/journal.pone.0255378.g002

According to our earlier results the size of SP from TMV depends on initial virus concentration [6]. Increasing the initial concentration of TMV leads to the formation of SP with a larger diameter. However, for SP from PVX and barley stripe mosaic virus, the size dependence of the particles formed on the initial concentration of the virus was not so clear [6,19].

AltMV SPV were obtained with initial concentrations 0.1, 1, 2 and 5 mg/ml. AltMV with a concentration of 0.1 mg/ml formed SP with a mean diameter of 124 ± 31 nm. Increasing virus concentration to 1 mg/ml led to the formation of SP with a mean diameter of 160 ± 48 nm. A further increase of initial virus concentration to 2–5 mg/mL had no substantial effect on the particles’ size (S2 Fig).

It is important to note that, after the heating of different AltMV VLPs samples (obtained during different AltMV CP isolation) with the same concentration, SPVLP with various mean diameters were obtained. In our previous work [19], we reported that the average diameter of SPVLP obtained from AltMV VLPs at a concentration of 0.1 and 1.0 mg/ml was 100 nm. In the present study, preparations of SPVLP with a mean diameter of 70 ± 10 nm, 118 ± 13 nm and 157 ± 28 nm, from 1.0 mg/ml of AltMV VLPs, were obtained. SPVLP size probably depends on the efficiency of AltMV VLPs’ assembly. It is not clear which factors impact on the efficiency of AltMV CP polymerisation into VLPs, however; this aspect requires additional research.

To analyse the biochemical component elements of AltMV SPV, the following experiment was conducted. AltMV SPV with a concentration of 1 mg/ml were precipitated by low-speed centrifugation, as described in Materials and Methods. The SPV pellet was resuspended in Milli-Q water and was used for RNA isolation (sample 1). Also, RNA was extracted from supernatant (sample 2), from intact SPV preparation which had not been centrifuged (sample 3) and from an equal quantity of untreated AltMV virions (sample 4). No viral RNA was detected in sample 1 (Fig 3, lane 5). At the same time, residual non-degraded RNA was observed in samples 2 and 3 (Fig 3, lane 4 and 3, respectively). It is worth emphasising that these samples were obtained by heating AltMV virions to 98°C for 30 sec. Nevertheless, some part of RNA was preserved intact after such thermal treatment. This RNA could be detected if the sample was not precipitated (Fig 3, lane 3) and SPV were not separated from supernatant. Remarkably, previously, in the case of PVX and TMV SP, complete RNA degradation was demonstrated upon heating at 94-98°C for 10 sec [5,6]. Despite the presence of RNA in the non-centrifuged sample (Fig 3, lane 3), no RNA was detected in SPV that were purified from supernatant (Fig 3, lane 5). Thus, AltMV SPV, as well as those of TMV and PVX, consisted exclusively of thermally denatured CP and did not contain viral RNA.

[Figure omitted. See PDF.]

Fig 3. Characterisation of the RNA state within the AltMV SPV.

1) AltMV RNA (positive control)– 6606 nt; 2) RNA isolated from AltMV virions (sample 4); 3) RNA isolated from non-centrifuged AltMV SPV (sample 3); 4) RNA isolated from supernatant after SPV low-speed centrifugation (sample 2); 5) RNA isolated from SPV pellet after low-speed centrifugation (sample1); 6) negative control (Milli-Q water passed through all procedures similar to samples). Virions were heated to 98°C for 30 sec. Electrophoretic analysis in 1% agarose gel. The gel was stained with ethidium bromide.

https://doi.org/10.1371/journal.pone.0255378.g003

SPV and SPVLP protein component was also analysed. No degradation or fragmentation of AltMV CP occurred upon the heating of virions and SP formation from AltMV virions (S3 Fig, lane 4). The same results were obtained for SPVLP (S3 Fig, lane 6).

Previously, we have reported considerable changes in the CP structure of other helical viruses (TMV, PVX) after thermal transition to SP [6,7]. In the current work, similar structural shifts after thermal remodelling of AltMV virions and VLPs were observed. For this purpose, circular dichroism (CD), intrinsic fluorescence spectroscopy and thioflavin T (ThT) assay were used. The CD spectra of AltMV virions, VLPs, SPV and SPVLP (Fig 4) were processed using program K2D3. The prediction of secondary structure is presented in Table 1.

[Figure omitted. See PDF.]

Fig 4.

Far-UV CD spectra of A) AltMV virions (1) and SPV (2); B) AltMV VLPs (3) and SPVLP (4). The initial virus and VLPs concentration was 1 mg/ml. The spectra were recorded at 25°С. The solution details are specified in Materials and Methods. Two repeated experiments were carried out with similar results. The spectra presented in the figure are the visualization of one repetition.

https://doi.org/10.1371/journal.pone.0255378.g004

[Figure omitted. See PDF.]

Table 1. Comparison of secondary structure content in protein in AltMV VLPs and AltMV SPV/VLP.

https://doi.org/10.1371/journal.pone.0255378.t001

The analysis of the data obtained confirmed that, similar to SP from TMV and PVX, AltMV SPV and SPVLP formation was accompanied by alteration of secondary structure. The content of α-helices in CP in AltMV virions and VLPs was higher than in protein within both types of SP. At the same time, the proportion of β-structure increased after thermal treatment.

The intrinsic fluorescence spectra demonstrated the shift of maximum fluorescence from 334±2 nm (AltMV CP contains 2 Trp and 3 Tyr residues) to 344±2 nm (AltMV SPV and SPVLP) (Fig 5). The maximum wavelength shifts for AltMV SPV and SPVLP indicate that Trp and Tyr residues were located in the more hydrophilic environment in SP. The similar transition of the fluorescence maximum to a longer wavelength region had been observed previously, in the context of TMV [7] and PVX SP [6].

[Figure omitted. See PDF.]

Fig 5.

Intrinsic fluorescence spectra of A) AltMV VLPs (1) and SPVLP (2); B) AltMV virions (3) and SPV (4). The spectra were recorded at 25°C. The solution details are specified in Materials and Methods. Three repeated experiments were carried out with similar results. The spectra presented in the figure are the visualization of one repetition.

https://doi.org/10.1371/journal.pone.0255378.g005

The ThT assay showed the presence of cross-β-structure SPVLP and SPV (S4 Fig), which is consistent with data for SP from TMV [7] and PVX [6]. Interestingly, the fluorescence intensity for SPV was twice as high as that of SPVLP. This indicates, indirectly, that SPV from virions contain more cross-β-structure than SPVLP, which is consistent with data obtained by CD spectroscopy (Table 1). It might be suggested that this result may be related to differences in the structure of AltMV virions and VLPs. As demonstrated earlier, using cryoelectron microscopy and the trypsin test, AltMV virions and VLPs have structural differences, despite their morphological similarity [4].

Plant viruses are an exceptionally attractive and versatile tool for biotechnology because of their biosafety for mammals. One of the attractive properties of plant virus-based SP is their ability to bind target molecules on the surface [5,6,9,11,27–29]. In the present work, preliminary data have shown that AltMV SPV and SPVLP could also be used as a platform for biotechnological purposes. To demonstrate adsorption properties of AltMV SPV/VLP, complexes with the model antigen were obtained (recombinant protein TM2e containing repeated sequences of influenza virus A M2e epitope, MW 24 kDa). SPV–TM2e and SPVLP–TM2e complexes were prepared by simple mixing with a mass ratio of 10:1 and they were analysed by immunofluorescence microscopy (Figs 6 and S5).

[Figure omitted. See PDF.]

Fig 6. Immunofluorescence microscopy of compositions comprising SP with recombinant protein TM2e adsorbed to their surface.

A) Complexes with SPV: 1.–fluorescence image. 2.–the same image in phase contrast. B) Complexes with SPVLP: 1.–fluorescence image. 2.–the same image in phase contrast. Detection with primary antibodies and secondary antibodies conjugated with fluorophore Alexa 546.

https://doi.org/10.1371/journal.pone.0255378.g006

The fluorescence images of both complexes (Fig 6A1 and 6B1) correspond to the phase contrast images (Fig 6A2 and 6B2). Comparing the images, it can be concluded that all SP in the camera field are covered by the model antigen. This also indicates that the model antigen preserves antigenic specificity within complexes. The absence of fluorescence in the negative control samples (S5 Fig), which were not treated with primary antibodies, confirmed that fluorescence-detected binding was specific. Therefore, it has been established that both SPV and SPVLP form complexes with target protein by non-covalent adsorption in vitro.

To continue to characterise the biotechnological potential of AltMV SP, surface amino and thiol groups’ reactivity was studied by using Fluorescein isothiocyanate (FITC) and 5-(N-Maleimido)-fluorescein diacetate. AltMV CP contains eight Lys which could bind FITC and two Cys potentially available to 5-(N-Maleimido)-fluorescein diacetate. SPV and SPVLP were labelled using two dyes and the particles obtained were studied using fluorescence microscopy (Fig 7). According to the results, both fluorophore molecules were successfully incorporated into the AltMV SPV and SPVLP.

[Figure omitted. See PDF.]

Fig 7. AltMV SP fluorescence labelling.

A) SPV bind FITC. B) SPVLP bind FITC. C) SPVLP bind 5-(N-Maleimido)-fluorescein diacetate. D) SPV bind 5-(N-Maleimido)-fluorescein diacetate. 1 –fluorescence image, 2 –phase contrast image.

https://doi.org/10.1371/journal.pone.0255378.g007

SDS-PAGE electrophoresis, with subsequent visualisation using UV-light (S6 Fig), demonstrated that AltMV VLPs and both types of SP interact with Fluorescein isothiocyanate (FITC) and 5-(N-Maleimido)-fluorescein diacetate considerably effective than AltMV virions. This means that Lys and Cys amino acid residues that are not available on virions’ surface become exposed on AltMV VLPs, SPV and SPVLP. Comparing the fluorescence intensity of labelled virions and VLPs it can be concluded that CP within virions and VLPs possess different surface amino acids composition. Thus, we completed our earlier results [4] obtained using the indirect method of trypsin test. It demonstrated the alteration of trypsin hydrolysis sites presented on the surface of AltMV virions and VLPs.

The thermal denaturation of AltMV virions probably led to the appearance on SPV surface amino acids capable of reacting with FITC and 5-(N-Maleimido)-fluorescein diacetate. The same conclusions had been reached for TMV virions and TMV SP labelled by FITC [12]. These data suggest that AltMV VLPs, SPV and SPVLP are attractive for amino groups’ labelling/conjugation. Herewith, AltMV SPV/VLP is more promising than virions and VLPs for thiol labelling/conjugation.

Thus, the possibility of SPV formation from AltMV virions has been described for the first time. Differences in the thermal remodelling of AltMV virions and VLPs were detected. AltMV virions transformed into SPV via intermediate forms, as demonstrated for TMV and PVX. AltMV VLPs converted to SPVLP without analogous intermediates. The temperature of the complete structural transition of AltMV virions was 94°C, and for VLPs it was 65°C. According to the biochemical analysis, SPV did not contain viral RNA. Therefore, both SPV/VLP are exclusively protein particles. Differences in the secondary and tertiary structures of CP within untreated virions, VLPs and SPV/VLP, were revealed. The intrinsic fluorescence spectra demonstrate that Trp and Tyr residues are located in the more hydrophilic environment in SPV/VLP. CP within SPV/VLP contained more β-structures and fewer α-helixes than virions and VLPs. This is a reflection of SPV/VLP formation being accompanied by significant changes in secondary and tertiary structures. The possibility of bioconjugation reactions targeted at Lys and Cys amino acid residues in AltMV SPV/VLP has been demonstrated. In this way, AltMV SPV/VLP represent protein platforms with exposed on their surface Lys/Cys amino acids. This makes it possible to apply AltMV SPV/VLP as a base for the formation of functionally active complexes through conjugation with surface reactive amino acid residues or through non-specific adsorption.

Supporting information

S1 Fig. Selection of conditions for AltMV SPV formation.

A) PBS, pH 7.4; B) Milli-Q; C) 0.01 M Tris-HCl, pH 8.0; D) 0.001 M citrate buffer, pH 4–4.2; E) phosphate buffer, pH 7.4; F) 0.15 M NaCl. Thermal treatment at 98°C for 30 sec. Transmission electron microscopy, staining with 2% uranyl acetate. Bars, 1μm.

https://doi.org/10.1371/journal.pone.0255378.s001

(TIF)

S2 Fig. Mean diameter of AltMV SPV with initial concentrations of 0.1, 1, 2 and 5 mg/ml.

Summary data from four separate samples of SPV for each concentration. Error bars represent standard deviation. Statistical differences were analysed using one-way ANOVA with a post hoc Tukey HSD Test, **p <0.01.

https://doi.org/10.1371/journal.pone.0255378.s002

(TIF)

S3 Fig. Characterisation of protein state in AltMV SPV/VLP.

1) Protein molecular weight markers, kDa; 2) 3) AltMV virions; 4) AltMV SPV; 5) AltMV VLPs; 6) AltMV SPVLP. 8–20% SDS-PAGE, staining with Coomassie G-250.

https://doi.org/10.1371/journal.pone.0255378.s003

(TIF)

S4 Fig. Thioflavin fluorescence spectra of AltMV virions (1), VLPs (3), SPV (2) and SPVLP (4) with an initial concentration of 1 mg/ml.

Spectra were recorded at 25°C. The solution details are specified in Materials and Methods. Three repeated experiments were carried out with similar results. The spectra presented in the figure are the visualization of one repetition.

https://doi.org/10.1371/journal.pone.0255378.s004

(TIF)

S5 Fig. Negative controls to the experiment presented in Fig 6.

The samples were prepared in the same way as in the experiment (see Fig 6) but the primary antibodies were not added. A) Complexes with SPV: 1.–Fluorescence image. 2.–the same image in phase contrast. B) Complexes with SPVLP: 1.–Fluorescence image. 2.–the same image in phase contrast. Immunofluorescence microscopy. Secondary antibodies conjugated with fluorophore Alexa 546.

https://doi.org/10.1371/journal.pone.0255378.s005

(TIF)

S6 Fig. AltMV CP fluorescence labelling.

A) Labelling by FITC. AltMV within the following structures: lane 3 –AltMV virions, lane 4 –AltMV VLPs, lane 5 –AltMV SPV, lane 6 –AltMV SPVLP. Lane 1 –protein molecular weight markers, kDa, lane 2 –unlabelled AltMV virions. 8–20% SDS-PAGE. A1) Staining with Coomassie G-250, A2) visualisation in UV-light. B) Labelling by 5-(N-Maleimido)-fluorescein diacetate. AltMV CP included in the following structures: lanes 2,3 –AltMV VLPs, lanes 4,5 –AltMV SPVLP, lanes 6,7 –AltMV virions, lanes 8,9 –AltMV SPV. B1) Staining with Coomassie G-250, B2) visualisation in UV-light.

https://doi.org/10.1371/journal.pone.0255378.s006

(TIF)

S1 Raw images.

https://doi.org/10.1371/journal.pone.0255378.s007

(PDF)

Acknowledgments

The work was carried out in the framework of the following scientific directions: Interdisciplinary Scientific and Educational School of Moscow University «Molecular Technologies of the Living Systems and Synthetic Biology», Scientific Project of the State Order of the Government of RF to Lomonosov MSU “Plant viruses and artificial virus-like particles: a study of the biological and structural features and application in biotechnology” №121032500078–5. The experiments were performed using the equipment purchased on account of the Lomonosov MSU Development Program.

Citation: Manukhova TI, Evtushenko EA, Ksenofontov AL, Arutyunyan AM, Kovalenko AO, Nikitin NA, et al. (2021) Thermal remodelling of Alternanthera mosaic virus virions and virus-like particles into protein spherical particles. PLoS ONE 16(7): e0255378. https://doi.org/10.1371/journal.pone.0255378

References

1. Geering ADW, Thomas JE. Characterization of a virus from Australia that is closely related to papaya mosaic potexvirus. Arch Virol. 1999;144(3):577–92. pmid:10226621

2. Ivanov PA, Mukhamedzhanova AA, Smirnov AA, Rodionova NP, Karpova OV, Atabekov JG. The complete nucleotide sequence of Alternanthera mosaic virus infecting Portulaca grandiflora represents a new strain distinct from phlox isolates. Virus Genes. 2011; 45:268–71. pmid:21127957

3. Mukhamedzhanova AA, Smirnov AA, Arkhipenko MV, Ivanov PA, Chirkov SN, Rodionova NP, at al. Characterization of Alternanthera mosaic virus and its coat protein. Open Virol. J. 2011;5:136–140. pmid:22216073

4. Donchenko EK, Pechnikova EV, Mishyna MY, Manukhova TI, Sokolova OS, Nikitin NA, et al. Structure and properties of virions and virus-like particles derived from the coat protein of Alternanthera mosaic virus. PLoS One. 2017;12(8):e0183824. pmid:28837650

5. Atabekov JG, Nikitin NA, Arkhipenko MV. Chirkov SN, Karpova OV. Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles. J. Gen. Virol. 2011;92(Pt 2):453–456. pmid:20980527

6. Nikitin NA, Ksenofontov AL, Trifonova EA, Arkhipenko MV, Petrova EK, Kondakova OA, et al. Thermal conversion of filamentous potato virus X into spherical particles with different properties from virions. FEBS Lett. 2016;590(10):1543–1551. pmid:27098711

7. Dobrov EN, Nikitin NA, Trifonova EA, Parshina EY, Makarov VV, Maksimov GV, et al. β-structure of the coat protein subunits in spherical particles generated by tobacco mosaic virus thermal denaturation. J. Biomol. Struct. Dyn. 2014;32(5):701–708. pmid:24404770

8. Nikitin NA, Malinin AS, Rakhnyanskaya AA, Trifonova EA, Karpova OV, Yaroslavov AA, et al. Use of a polycation spacer for noncovalent immobilization of albumin on thermally modified virus particles. Polym. Sci. Ser. 2011;A53:1026–1031.

9. Karpova OV, Nikitin NA, Chirkov SN, Trifonova EA, Sheveleva AA, Lazareva EA, et al. Immunogenic compositions assembled from tobacco mosaic virus-generated spherical particle platforms and foreign antigens. J Gen Virol. 2012;93(Pt 2):400–407. pmid:22049093

10. Trifonova EA, Nikitin NA, Gmyl AP, Lazareva EA, Karpova OV, Atabekov JG. Complexes assembled from TMV-derived spherical particles and entire virions of heterogeneous nature. J. Biomol. Struct. Dyn. 2014;32L:1193–1201. pmid:24099636

11. Trifonova EA, Zenin VA, Nikitin NA, Yurkova MS, Ryabchevskaya EM, Putlyaev EV, et al. Study of rubella candidate vaccine based on a structurally modified plant virus. Antiviral Res. 2017; 144: 27–33. pmid:28511994

12. Ksenofontov AL, Fedorova NV, Badun GA, Serebryakova MV, Nikitin NA, Evtushenko EA, et al. Surface characterization of the thermal remodeling helical plant virus. PLoS One. 2019;14(5):e0216905. pmid:31150411

13. Murray AA, Wang C, Fiering S, Steinmetz NF. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma. Mol Pharm. 2018;15(9):3700–3716. pmid:29798673

14. Bruckman MA, Hern S, Jiang K, Flask CA, Yu X, Steinmetz NF. Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents. J Mater Chem B. 2013;1(10):1482–1490. pmid:23589767

15. Shah S, Shah S, Heddle J. Wild-type tobacco mosaic virus (TMV) as a scaffold for gold nanoparticle fabrication. Proceedings of the 6th International Conference on Gold Science, Technbology and its Applications; 2P–072. 2012. Tokyo.

16. Rodriguez-Galvan A, Martinez-Loran E, Naveja JJ, Ornelas-Soto N, Basiuk V, Contreras-Torres FF. In-situ metallization of thermally-treated tobacco mosaic virus using silver nanoparticles. J. Nanosci. Nanotechnol. 2017;17(7):4740–4747(8);

17. Maduray K, Parboosing R. Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections. Biol Trace Elem Res. 2020;1–18. pmid:33029761

18. Aderibigbe BA. Metal-Based Nanoparticles for the Treatment of Infectious Diseases. Molecules. 2017;22(8):1370. pmid:28820471

19. Trifonova EA., Nikitin NA, Arkhipenko MV, Donchenko EK, Karpova OV, Atabekov JG. Comparative study of thermal remodeling of viruses with icosahedral and helical symmetry. Moscow Univ. Biol.Sci. Bull. 2017:72:179–183.

20. Karpova OV, Arkhipenko MV, Zayakina OV, Nikitin NA, Kiselyova OI, Kozlovsky SV, et al. Regulation of RNA translational in potato virus X RNA-coat protein complexes: the key role of the N-terminal segment of the protein. Mol Biol (Mosk). 2006;40(4):703–710.

21. Fraenkel-Conrat H, Singer B, Tsugita A. Purification of viral RNA by means of bentonite. Virology. 196;14:54–8. pmid:13701154

22. Miroshnichenko NA, Karpova OV, Morozov SYu, Rodionova NP, Atabekov JG. Translation arrest of potato virus X RNA in Krebs-2 cell-free system: RNase H cleavage promoted by complementary oligodeoxynucleotides. FEBS Lett. 1988; 4;234(1):65–8. pmid:2839367

23. Ksenofontov AL, Parshina EY, Fedorova NV, Arutyunyan AM, Rumvolt R, Paalme V, et al. Heating-induced transition of potyvirus potato virus A coat protein into β-structure. J Biomol Struct Dyn. 2016;34(2):250–258. pmid:25851284

24. Nanda JS, Lorsch JR. Chapter Seven—Labeling of a Protein with Fluorophores Using Maleimide Derivitization. Lorsch JR, editor. Methods in Enzymology, Academic Press, V. 536, 2014, P.79–86. https://doi.org/10.1016/B978-0-12-420070-8.00007-6 pmid:24423268

25. Wang D, Zheng Z, Feng J, Zhan X, Zhang LM, Li-Min W, et al. Influence of sodium chloride on thermal denaturation of a high-salt-tolerant neutral protease from Aspergillus oryzae. Food Sci. Biotechnol. 2013; 22(5):1–7.

26. Semenyuk PI, Karpova OV, Ksenofontov AL, Kalinina NO, Dobrov EN, Makarov VV. Structural properties of potexvirus coat proteins detected by optical methods. Biochemistry (Mosc). 2016 Dec;81(12):1522–1530. pmid:28259129

27. Nikitin NA, Zenin VA, Trifonova EA, Ryabchevskaya EM, Kondakova OA, Fedorov AN, et al. Assessment of structurally modified plant virus as a novel adjuvant in toxicity studies. Regul. Toxicol. Pharmacol. 2018;97:127–133. pmid:29932979

28. Nikitin NA, Zenin VA, Trifonova EA, Ryabchevskaya EM, Yurkova MS, Kondakova OA, et al. Data in support of toxicity studies of structurally modified plant virus to safety assessment. Data Brief. 2018;21:1504–1507. pmid:30510980

29. Nikitin NA, Matveeva IN, Trifonova EA, Puhova NM, Samuylenko AY, Gryn SA, et al. Spherical particles derived from TMV virions enhance the protective properties of the rabies vaccine. Data Brief. 2018;21:742–745. pmid:30406165